AGL 37.01 Decreased By ▼ -0.99 (-2.61%)
AIRLINK 132.60 Decreased By ▼ -4.09 (-2.99%)
BOP 5.51 Increased By ▲ 0.09 (1.66%)
CNERGY 3.79 Decreased By ▼ -0.04 (-1.04%)
DCL 7.48 Decreased By ▼ -0.11 (-1.45%)
DFML 44.81 Decreased By ▼ -1.24 (-2.69%)
DGKC 81.20 Increased By ▲ 0.85 (1.06%)
FCCL 28.65 Increased By ▲ 0.62 (2.21%)
FFBL 54.75 Decreased By ▼ -0.46 (-0.83%)
FFL 8.55 Decreased By ▼ -0.03 (-0.35%)
HUBC 107.90 Decreased By ▼ -4.75 (-4.22%)
HUMNL 13.56 Increased By ▲ 1.23 (9.98%)
KEL 3.81 Decreased By ▼ -0.04 (-1.04%)
KOSM 7.04 Decreased By ▼ -1.03 (-12.76%)
MLCF 36.25 Increased By ▲ 1.14 (3.25%)
NBP 67.30 Increased By ▲ 1.30 (1.97%)
OGDC 169.49 Decreased By ▼ -1.67 (-0.98%)
PAEL 24.88 Decreased By ▼ -0.30 (-1.19%)
PIBTL 6.15 Decreased By ▼ -0.05 (-0.81%)
PPL 130.70 Decreased By ▼ -2.15 (-1.62%)
PRL 24.50 Increased By ▲ 0.10 (0.41%)
PTC 15.77 Increased By ▲ 1.25 (8.61%)
SEARL 57.80 Decreased By ▼ -1.15 (-1.95%)
TELE 6.99 Decreased By ▼ -0.10 (-1.41%)
TOMCL 34.73 Decreased By ▼ -0.27 (-0.77%)
TPLP 7.70 Decreased By ▼ -0.39 (-4.82%)
TREET 13.96 Decreased By ▼ -0.34 (-2.38%)
TRG 44.25 Decreased By ▼ -1.34 (-2.94%)
UNITY 25.15 Decreased By ▼ -0.84 (-3.23%)
WTL 1.18 Decreased By ▼ -0.02 (-1.67%)
BR100 9,082 Decreased By -1.8 (-0.02%)
BR30 27,380 Decreased By -251 (-0.91%)
KSE100 85,483 Increased By 30.2 (0.04%)
KSE30 27,160 Increased By 10.7 (0.04%)

For people with a certain type of migraine headache, regular acupuncture treatments may help reduce the frequency of these debilitating attacks, a recent study from China suggests. Patients who suffered migraines without aura, and who received five true acupuncture treatments per week for four consecutive weeks had about one less headache per month than similar patients who got the same number of sham acupuncture treatments, researchers report.
"Acupuncture should be considered as one option for migraine prophylaxis in light of our findings," the authors write in JAMA Internal Medicine. About 18 percent of women and 6 percent of men in the US suffer from migraine headaches in a given year, according to a 2001 study, making the condition a leading cause of disability.
Acupuncture is commonly used to treat migraines in China, however, studies of whether it works for migraine prevention have been inconsistent, the study team notes.
Ling Zhao of Chengdu University of Traditional Chinese Medicine in Sichuan, China, and colleagues recruited 249 adults who had an average of two to eight migraines without aura per month from three clinical centers in China.
For the study, participants kept track of their migraine headache frequency and severity for four weeks before being randomly assigned to receive true acupuncture treatment, sham acupuncture treatment or to be put on a waiting list for treatment.
People in both the true and sham acupuncture groups received 20 treatments with acupuncture needles and electrical stimulation, each lasting thirty minutes. The true acupuncture group was treated at four acupuncture points thought to affect headaches and with enough electrical stimulation to elicit a "Deqi" sensation, which includes "soreness, numbness, distention or radiation that indicated effective needling," according to the authors.
For the sham treatment, the needles were placed in areas not known to be acupuncture points and the deqi sensation wasn't induced.
At 16 weeks, the number of migraines reported in the true acupuncture group fell by about three attacks per month, while people in the sham acupuncture group had two fewer attacks per month. Among the study's limitations, about 20 percent of the participants had previous experience with acupuncture, and it's not known how many may have been able to guess whether their treatments were real or sham.
"Placebo response is strong in migraine treatment studies, and it is possible that the Deqi sensation that was elicited in the true acupuncture group could have led to a higher degree of placebo response because there was no attempt made to elicit the Deqi sensation in the sham acupuncture group," Dr Amy Gelfand writes in an accompanying editorial.

Copyright Reuters, 2017

Comments

Comments are closed.